J.P. Morgan Private Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $876K | Sell |
7,789
-174
| -2% | -$19.6K | ﹤0.01% | 1029 |
|
|
2023
Q2 | $751K | Sell |
7,963
-3,057
| -28% | -$288K | ﹤0.01% | 871 |
|
|
2023
Q1 | $1.12M | Sell |
11,020
-49
| -0.4% | -$4.96K | ﹤0.01% | 1119 |
|
|
2022
Q4 | $1.32M | Buy |
11,069
+113
| +1% | +$13.5K | ﹤0.01% | 1022 |
|
|
2022
Q3 | $1.16M | Sell |
10,956
-207
| -2% | -$22K | ﹤0.01% | 1061 |
|
|
2022
Q2 | $1.09M | Buy |
11,163
+311
| +3% | +$30.3K | ﹤0.01% | 1102 |
|
|
2022
Q1 | $1.02M | Buy |
10,852
+4,190
| +63% | +$393K | ﹤0.01% | 1216 |
|
|
2021
Q4 | $567K | Sell |
6,662
-2,413
| -27% | -$205K | ﹤0.01% | 1500 |
|
|
2021
Q3 | $870K | Buy |
9,075
+1,373
| +18% | +$132K | ﹤0.01% | 1279 |
|
|
2021
Q2 | $750K | Buy |
7,702
+1,672
| +28% | +$163K | ﹤0.01% | 1326 |
|
|
2021
Q1 | $586K | Sell |
6,030
-2,180
| -27% | -$212K | ﹤0.01% | 1250 |
|
|
2020
Q4 | $787K | Sell |
8,210
-26
| -0.3% | -$2.49K | ﹤0.01% | 1096 |
|
|
2020
Q3 | $792K | Buy |
8,236
+849
| +11% | +$81.6K | ﹤0.01% | 976 |
|
|
2020
Q2 | $901K | Buy |
7,387
+456
| +7% | +$55.6K | ﹤0.01% | 851 |
|
|
2020
Q1 | $600K | Buy |
6,931
+4,083
| +143% | +$353K | ﹤0.01% | 870 |
|
|
2019
Q4 | $306K | Buy |
2,848
+293
| +11% | +$31.5K | ﹤0.01% | 1232 |
|
|
2019
Q3 | $230K | Sell |
2,555
-8,626
| -77% | -$777K | ﹤0.01% | 1293 |
|
|
2019
Q2 | $944K | Buy |
+11,181
| New | +$944K | 0.01% | 771 |
|
|
2018
Q4 | – | Sell |
-23,491
| Closed | -$2.89M | – | 1542 |
|
|
2018
Q3 | $2.89M | Sell |
23,491
-188
| -0.8% | -$23.1K | 0.01% | 549 |
|
|
2018
Q2 | $2.33M | Buy |
23,679
+6
| +0% | +$589 | 0.01% | 571 |
|
|
2018
Q1 | $1.96M | Buy |
23,673
+62
| +0.3% | +$5.14K | 0.01% | 488 |
|
|
2017
Q4 | $1.83M | Sell |
23,611
-81
| -0.3% | -$6.29K | 0.01% | 503 |
|
|
2017
Q3 | $1.45M | Buy |
23,692
+60
| +0.3% | +$3.68K | 0.01% | 534 |
|
|
2017
Q2 | $1.09M | Buy |
23,632
+1
| +0% | +$46 | 0.01% | 597 |
|
|
2017
Q1 | $1.02M | Buy |
23,631
+231
| +1% | +$10K | 0.01% | 621 |
|
|
2016
Q4 | $906K | Hold |
23,400
| – | – | 0.01% | 620 |
|
|
2016
Q3 | $1.19M | Sell |
23,400
-2,623
| -10% | -$133K | 0.01% | 550 |
|
|
2016
Q2 | $1.18M | Sell |
26,023
-589
| -2% | -$26.8K | 0.01% | 552 |
|
|
2016
Q1 | $1.05M | Sell |
26,612
-62
| -0.2% | -$2.45K | 0.01% | 548 |
|
|
2015
Q4 | $1.51M | Sell |
26,674
-7,530
| -22% | -$426K | 0.02% | 434 |
|
|
2015
Q3 | $1.36M | Sell |
34,204
-6,071
| -15% | -$242K | 0.02% | 409 |
|
|
2015
Q2 | $1.92M | Sell |
40,275
-1,985
| -5% | -$94.8K | 0.02% | 374 |
|
|
2015
Q1 | $1.68M | Sell |
42,260
-9,740
| -19% | -$387K | 0.02% | 410 |
|
|
2014
Q4 | $1.16M | Hold |
52,000
| – | – | 0.01% | 496 |
|
|
2014
Q3 | $815K | Hold |
52,000
| – | – | 0.01% | 560 |
|
|
2014
Q2 | $771K | Hold |
52,000
| – | – | 0.01% | 461 |
|
|
2014
Q1 | $837K | Buy |
+52,000
| New | +$837K | 0.02% | 439 |
|